Canada markets closed

Aprea Therapeutics, Inc. (APRE)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.10-0.16 (-2.95%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 27.61M
Enterprise Value -1.18M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.63
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.08

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 332.47%
S&P500 52-Week Change 323.10%
52 Week High 38.85
52 Week Low 32.78
50-Day Moving Average 36.35
200-Day Moving Average 34.83

Share Statistics

Avg Vol (3 month) 332.96k
Avg Vol (10 day) 36.27k
Shares Outstanding 55.43M
Implied Shares Outstanding 65.55M
Float 84.19M
% Held by Insiders 111.67%
% Held by Institutions 117.69%
Shares Short (Apr 15, 2024) 496.18k
Short Ratio (Apr 15, 2024) 46.71
Short % of Float (Apr 15, 2024) 41.99%
Short % of Shares Outstanding (Apr 15, 2024) 41.77%
Shares Short (prior month Mar 15, 2024) 4117.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Feb 13, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-26,109.62%

Management Effectiveness

Return on Assets (ttm)-36.63%
Return on Equity (ttm)-63.19%

Income Statement

Revenue (ttm)583.23k
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.46M
Net Income Avi to Common (ttm)-14.29M
Diluted EPS (ttm)-3.95
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)21.61M
Total Cash Per Share (mrq)3.98
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.14
Book Value Per Share (mrq)4.54

Cash Flow Statement

Operating Cash Flow (ttm)-12.18M
Levered Free Cash Flow (ttm)-7.67M